Няма интернет връзка — показва се запазената версия на страницата.

Atara Biotherapeu…

USUSD
← Към Скрийнъра
US:ATRALSE:0HIY

Atara Biotherapeutics Inc (US:ATRA) — Biotechnology: Biological Products (No Diagnostic Substances). Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.

За Компанията

Уебсайт
atarabio.com
Връзки с Инвеститорите
investors.atarabio.com/news-events/press-releases
Сектор
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Централа
South San Francisco, United States
Изпълнителен Директор
Anhco Nguyen
Служители
10
Основана
2012
Акции в Обращение
10.04 млн към 2026-08-10
Свободно Търгуеми Акции
4.62 млн
Пазарна Капитализация
95.16 млн USD
Инсайдери
16.8%
Институционални Инвеститори
57.67%
Отрасъл (SIC)
Biological Products, (No Diagnostic Substances)
LEI
549300WBXUXZRE03MS38
FCF
−50.9 млн USD
Дълг
0
Печалби и FCF — за 12-те месеца до 30.06.2026 (последният доклад на компанията).
Описание

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Борси и Тикери

БорсаТикерВалутаЦенаВид
US USA StocksATRA основенUSD9.23 -1.49%обикновени акции
LSE London Stock Exchange0HIY IOBUSD9.01 +0.00%обикновени акции

Цена за 3 Месеца

ден на ръст ден на спадПосочете / докоснете ден — цени на отваряне, затваряне, най-висока и най-ниска
реклама

Най-Големи Притежатели

ПритежателДялАкцииДата на Доклада
EcoR1 Capital, LLC15.46%1.55 млн2026-06-30
CIONGOLI GREGORY AUSTIN…≈12.17%1.22 млн2026-06-09
Adage Capital Partners G…8.47%850 0002026-06-30
Point72 Asset Management…6.85%687 7182026-06-30
Redmile Group, LLC4.4%441 7012026-06-30
Vanguard Capital Managem…2.46%247 0472026-06-30
Mackenzie Financial Corp…2.32%233 2492026-06-30
CHERRY BRIAN N (Director…≈1.66%166 4862026-09-04
VANGUARD INDEX FUNDS-Van…1.58%158 6462026-06-30
NGUYEN ANHCO T (Chief Ex…≈1.32%132 7752026-08-17
Blackrock Inc.0.84%84 4552026-06-30
VANGUARD INDEX FUNDS-Van…0.82%82 7582026-06-30
TOUCHON PASCAL (Director…≈0.78%77 9552025-06-10
Geode Capital Management…0.75%75 1282026-06-30
HYLLENGREN ERIC J (Chief…≈0.56%56 2312025-03-03
Staley Capital Advisers,…0.5%50 0002026-06-30
Vanguard Fiduciary Trust…0.43%43 0362026-06-30
Fidelity Concord Street…0.35%35 3922026-07-31
iShares Trust-iShares Mi…0.19%18 8242026-08-31
Varbl Insurance Prod. Fd…0.16%16 2382026-07-31
Fidelity Concord Street…0.11%11 1752026-07-31
Fidelity Concord Street…0.1%10 4792026-07-31
Fidelity Concord Street…0.05%4 6122026-07-31
VANGUARD Inst. INDEX Fd.…0.03%2 8442026-06-30
VANGUARD VALLEY FORGE FU…0.03%2 7992026-06-30
ADIUMENTUM CAPITAL FUND…——2025-05-16
ECOR1 CAPITAL, L.L.C. (B…——2026-05-07
PANACEA INNOVATION LTD (…——2026-05-07
PANACEA VENTURE (Benefic…——2025-11-28
REDMILE GROUP, L.L.C. (U…——2026-07-22